Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes
Continuous glucose monitoring technology with and without insulin pump therapy is an emerging attractive approach to help insulin-treated people with DKD optimise their glycaemic control
Potential Research Applications: Sleep regulation and circadian rhythm studies Stress adaptation and cortisol modulation research Neuroprotection and oxidative stress models Endocrine system and hormone balance investigations For laboratory research only
Teprotumumab for the Treatment of Active Thyroid Eye Disease
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 26.02
US$ 29.34
US$ 20.53
